Order Article Reprints

Simeakis G, Anagnostouli M, Fakas N, Koutsikos J, Papatheodorou A, Chanopoulos K, Athanasiou K, Papatheodorou G, Zapanti E, Alevizaki M, et al. High-Dose Intravenous Steroid Treatment Seems to Have No Long-Term Negative Effect on Bone Mineral Density of Young and Newly Diagnosed Multiple Sclerosis Patients: A Pilot Study. Biomedicines. 2023; 11(2):603. https://doi.org/10.3390/biomedicines11020603

Simeakis, George, Maria Anagnostouli, Nikolaos Fakas, John Koutsikos, Athanasios Papatheodorou, Konstantinos Chanopoulos, Kwnstantinos Athanasiou, George Papatheodorou, Evangelia Zapanti, Maria Alevizaki, and et al. 2023. "High-Dose Intravenous Steroid Treatment Seems to Have No Long-Term Negative Effect on Bone Mineral Density of Young and Newly Diagnosed Multiple Sclerosis Patients: A Pilot Study" Biomedicines 11, no. 2: 603. https://doi.org/10.3390/biomedicines11020603

Simeakis, G., Anagnostouli, M., Fakas, N., Koutsikos, J., Papatheodorou, A., Chanopoulos, K., Athanasiou, K., Papatheodorou, G., Zapanti, E., Alevizaki, M., Kaltsas, G., & Terpos, E. (2023). High-Dose Intravenous Steroid Treatment Seems to Have No Long-Term Negative Effect on Bone Mineral Density of Young and Newly Diagnosed Multiple Sclerosis Patients: A Pilot Study. Biomedicines, 11(2), 603. https://doi.org/10.3390/biomedicines11020603